Efficacy and Tolerability of Enstilar® in Daily Practice

Inclusion Criteria: * ≥ 18 years of age * Psoriasis vulgaris * Lesions on trunk and/or extremities of at least mild severity * Treatment with Enstilar® planned * Signed informed consent to participate Exclusion Criteria: * Enrolled in any interventional clinical trial * Ongoing or recent treatment with any systemic psoriasis * Ongoing or recent treatment with UV-therapy * Ongoing or previous treatment with Enstilar® * Psoriasis of scalp only * Other forms of psoriasis, e.g. erythrodermic or pustular psoriasis * More than 30% of surface area affected by psoriasis * Any contraindications or known allergies to Enstilar® or its ingredients * Incapacitated patients under institutionalized care